Vycor Medical (VYCO) Receivables (2010 - 2026)
Vycor Medical (VYCO) reported Receivables of $194041.0 for Q1 2026, down 15.42% year-over-year from $229411.0 in Q1 2025, and down 11.35% on a QoQ basis from $218891.0 in Q4 2025.
Vycor Medical (VYCO) has 17 years of Receivables data on file, last reported at $194041.0 in Q1 2026.
- Quarterly Receivables fell 15.42% year-over-year to $194041.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $194041.0 (down 15.42% YoY) and the FY2025 annual result came in at $218891.0, down 10.75% from the prior year.
- Receivables eased to $194041.0 in Q1 2026 per VYCO's latest filing, from $218891.0 in the prior quarter.
- Across five years, Receivables topped out at $326052.0 in Q3 2025 and bottomed at $156204.0 in Q4 2022.
- The 5-year median for Receivables is $218891.0 (2025), against an average of $223165.5.
- The widest annual swing landed in 2023, when Receivables jumped 41.38%; it then retreated 19.82% in 2025.
- Tracing VYCO's Receivables over 5 years: stood at $156204.0 in 2022, then jumped by 37.79% to $215231.0 in 2023, then advanced by 13.95% to $245260.0 in 2024, then declined by 10.75% to $218891.0 in 2025, then slipped by 11.35% to $194041.0 in 2026.
- Per Business Quant, the three latest VYCO Receivables figures stand at $194041.0 (Q1 2026), $218891.0 (Q4 2025), and $326052.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 8.21 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 3.57 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 6.36 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 3.15 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 973.00 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 3.82 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 1.11 Bn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 4.50 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 1.09 Bn |
| 10 | Vycor Medical | - | - | 375,153.00 | 194,041.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 194,041.00 |
| Dec 31, 2025 | 218,891.00 |
| Sep 30, 2025 | 326,052.00 |
| Jun 30, 2025 | 202,669.00 |
| Mar 31, 2025 | 229,411.00 |
| Dec 31, 2024 | 245,260.00 |
| Sep 30, 2024 | 238,700.00 |
| Jun 30, 2024 | 252,776.00 |
| Mar 31, 2024 | 244,069.00 |
| Dec 31, 2023 | 215,231.00 |
| Sep 30, 2023 | 255,266.00 |
| Jun 30, 2023 | 282,550.00 |
| Mar 31, 2023 | 177,897.00 |
| Dec 31, 2022 | 156,204.00 |
| Sep 30, 2022 | 180,558.00 |
| Jun 30, 2022 | 212,455.00 |
| Mar 31, 2022 | 161,783.00 |
| Dec 31, 2021 | 126,096.00 |
| Sep 30, 2021 | 176,884.00 |
| Jun 30, 2021 | 205,087.00 |
| Mar 31, 2021 | 143,856.00 |
| Dec 31, 2020 | 159,238.00 |
| Sep 30, 2020 | 137,397.00 |
| Jun 30, 2020 | 96,965.00 |
| Mar 31, 2020 | 163,038.00 |
| Dec 31, 2019 | 274,551.00 |
| Sep 30, 2019 | 214,807.00 |
| Jun 30, 2019 | 295,036.00 |
| Mar 31, 2019 | 259,957.00 |
| Dec 31, 2018 | 257,468.00 |
| Sep 30, 2018 | 245,154.00 |
| Jun 30, 2018 | 136,322.00 |
| Mar 31, 2018 | 130,483.00 |
| Dec 31, 2017 | 110,422.00 |
| Sep 30, 2017 | 238,129.00 |
| Jun 30, 2017 | 117,884.00 |
| Mar 31, 2017 | 247,728.00 |
| Dec 31, 2016 | 148,784.00 |
| Sep 30, 2016 | 116,849.00 |
| Jun 30, 2016 | 222,636.00 |
| Mar 31, 2016 | 162,371.00 |
| Dec 31, 2015 | 116,561.11 |
| Sep 30, 2015 | 112,763.00 |
| Jun 30, 2015 | 113,472.00 |
| Mar 31, 2015 | 166,046.00 |
| Dec 31, 2014 | 154,748.13 |
| Sep 30, 2014 | 151,899.00 |
| Jun 30, 2014 | 196,907.00 |
| Mar 31, 2014 | 289,018.00 |
| Dec 31, 2013 | 212,660.00 |
| Sep 30, 2013 | 199,675.00 |
| Jun 30, 2013 | 92,182.00 |
| Mar 31, 2013 | 83,619.00 |
| Dec 31, 2012 | 144,347.00 |
| Sep 30, 2012 | 140,796.00 |
| Jun 30, 2012 | 171,849.00 |
| Mar 31, 2012 | 314,651.00 |
| Dec 31, 2011 | 313,679.00 |
| Sep 30, 2011 | 113,575.00 |
| Jun 30, 2011 | 106,249.00 |
| Dec 31, 2010 | 76,460.00 |